Medinotec Inc. Quality Score

MDNC

⊜ Compare

Quality65

Growth remains strong (avg 100/100), but business quality is pulling the composite down (avg 75/100).

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Growth

Revenue Growth

100/100

78.8%

Above 10% CAGR, strong compounder

Cash Flow Growth

100/100

214.8%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution

60/100

0.2%

Mild dilution under 2%

Margin Trend

100/100

+30.5pp

Expanded 3+pp, strong improvement

Capital Structure

100/100

-$2M

Net cash position, no leverage concern

2023

$3.00M

$0.00

2024

$3.00M

$64014

2025

$3.00M

$40756

2026

$3.00M

$14905

TTM

$3.00M

$91165

CashDebt

Return on Capital

40/100

9.2%

8–10%, clearing the bar

Customize WeightsPremiumAdjust metric weights to match your investment style.Upgrade

SourceQuality score computed from the 10-Q filed 8 Oct 2026, covering the period ending 31 Aug 2026, as reported to the SEC. Data last refreshed 9 Oct 2026. How this is calculated.

Fiscal year ends Feb. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with MDNC

CompareIntrinsic value

NSPRInspireMD Inc.

$0.78+18.33%25

NMTCNeuroOne Medical Technologies Corporation

$0.95-3.06%40

NXGLNexGel Inc.

$4.01-10.49%30

ALURAllurion Technologies Inc.

$0.02+0.00%10

XAIRBeyond Air, Inc.

$2.33+0.43%30

IVFINVO Fertility, Inc.

$2.05+5.67%40

ECIAEncision Inc.

$0.03+160.87%14

PMIPicard Medical, Inc.

$7.19-7.58%30

Spot a number that looks wrong? Check it in MDNC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MDNC

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.